Endocrine oncology

Nuclear STAT3 expression is associated with favorable prognosis in papillary thyroid carcinoma

Eur Thyroid JPublished Retrospective cohort study

Authors' conclusion

n-STAT3 scores in cases with PTC were associated with favorable prognosis. Further studies are required to elucidate the mechanism.

Study context

Population
PTC cases with M0 diagnosed between 1993 and 20121,132 PTC cases included
Participants
764 vs 371
Exposure
High vs low nuclear STAT3 H-score
  • High n-STAT3n = 764
  • Low n-STAT3n = 371reference
Outcome
RFS by n-STAT3 score
Methodological detailsimmunohistochemical staining with anti-STAT3 antibody
  • Immunohistochemical staining with anti-STAT3 antibody

Main finding

As reported in the abstract

RFS

10-year RFS

20-year RFS

  • High n-STAT3 vs Low n-STAT3: P < 0.0001 — significantly better recurrence-free survival (RFS) with high n-STAT3

Observational data: associations, not effects.

Further findings

n-STAT3 score

Median n-STAT3 score
105

Factors associated with poor RFS

Age (≥55 years), tumor size (≥4 cm), extrathyroidal extension, larger maximum lymph node size (≥30 mm) and low n-STAT3 associated with poor RFS on univariate and multivariate analyses

Original publication

Nuclear STAT3 expression is associated with favorable prognosis in papillary thyroid carcinoma. Eur Thyroid J. Published 17 October 2025. doi:10.1530/etj-25-0080

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.